The treatment involves swallowing a sachet containing tiny carbon beads that are designed to remove toxins produced by bacteria in the gut and stop them attacking the liver.
The University of Brighton jointly developed the patent for this technology with UCL and a industry partner, and is also a partner in the Carbalive Consortium, an international collaboration set up to establish the safety and efficacy of the novel oral carbon therapy.
You can read the full story published in The Sunday Times 13 November 2016.